FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma
FDA Approves Isatuximab On-Body Injector, Raising Anti-CD38 Competition in Myeloma The American Journal of Managed Care
2026
Implantica receives FDA approval for RefluxStop® – Opening the U.S. market
Implantica receives FDA approval for RefluxStop® - Opening the U.S. market Yahoo Finance
FDA Approves Implantica’s RefluxStop for GERD Treatment
FDA Approves Implantica’s RefluxStop for GERD Treatment The Clinical Trial Vanguard